Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Total
Balance at Mar. 31, 2020 $ 10 $ 915,755 $ (900,869) $ (1,875) $ 13,021
Balance (in shares) at Mar. 31, 2020 10,286,366     57,577  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (4) (4)
Purchase of treasury stock (in shares)       3,442  
Vested restricted stock awards   4     4
Vested restricted stock awards (in shares) 16,126        
Stock-based compensation   210     210
Issuance of common stock, net of issuance costs $ 1 1,371     1,372
Issuance of common stock, net of issuance costs (in shares) 782,448        
Change in warrants valuation   99     99
Net loss     (1,823)   (1,823)
Balance at Jun. 30, 2020 $ 11 917,439 (902,692) $ (1,879) 12,879
Balance (in shares) at Jun. 30, 2020 11,084,940     61,019  
Balance at Mar. 31, 2020 $ 10 915,755 (900,869) $ (1,875) 13,021
Balance (in shares) at Mar. 31, 2020 10,286,366     57,577  
Increase (Decrease) in Stockholders' Equity          
Net loss         (6,035)
Balance at Sep. 30, 2020 $ 11 917,674 (906,919) $ (1,918) 8,848
Balance (in shares) at Sep. 30, 2020 11,143,708     70,422  
Balance at Jun. 30, 2020 $ 11 917,439 (902,692) $ (1,879) 12,879
Balance (in shares) at Jun. 30, 2020 11,084,940     61,019  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (39) (39)
Purchase of treasury stock (in shares)       9,403  
Vested restricted stock awards   39     39
Vested restricted stock awards (in shares) 1,670        
Stock-based compensation   219     219
Stock awards to Board of Directors   (38)     (38)
Stock awards to Board of Directors (in shares) 57,098        
Deemed dividend on purchase warrant for common shares   15 (15)    
Net loss     (4,212)   (4,212)
Balance at Sep. 30, 2020 $ 11 917,674 (906,919) $ (1,918) 8,848
Balance (in shares) at Sep. 30, 2020 11,143,708     70,422  
Balance at Mar. 31, 2021 $ 13 934,381 (919,271) $ (1,949) $ 13,174
Balance (in shares) at Mar. 31, 2021 12,898,144     73,954 12,824,190
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (29) $ (29)
Purchase of treasury stock (in shares)       3,353  
Vested restricted stock awards   29     29
Vested restricted stock awards (in shares) 19,096        
Stock-based compensation   305     305
Issuance of common stock, net of issuance costs $ 2 11,203     11,205
Issuance of common stock, net of issuance costs (in shares) 2,289,651        
Net loss     (2,182)   (2,182)
Balance at Jun. 30, 2021 $ 15 945,918 (921,453) $ (1,978) 22,502
Balance (in shares) at Jun. 30, 2021 15,206,891     77,307  
Balance at Mar. 31, 2021 $ 13 934,381 (919,271) $ (1,949) $ 13,174
Balance (in shares) at Mar. 31, 2021 12,898,144     73,954 12,824,190
Increase (Decrease) in Stockholders' Equity          
Net loss         $ (8,176)
Balance at Sep. 30, 2021 $ 15 946,278 (927,447) $ (2,070) $ 16,776
Balance (in shares) at Sep. 30, 2021 15,325,464     97,313 15,228,151
Balance at Jun. 30, 2021 $ 15 945,918 (921,453) $ (1,978) $ 22,502
Balance (in shares) at Jun. 30, 2021 15,206,891     77,307  
Increase (Decrease) in Stockholders' Equity          
Purchase of treasury stock       $ (92) (92)
Purchase of treasury stock (in shares)       20,006  
Vested restricted stock awards   53     53
Vested restricted stock awards (in shares) 48,313        
Stock-based compensation   333     333
Issuance of common stock, net of issuance costs   (26)     (26)
Stock awards to Board of Directors (in shares) 70,260        
Net loss     (5,994)   (5,994)
Balance at Sep. 30, 2021 $ 15 $ 946,278 $ (927,447) $ (2,070) $ 16,776
Balance (in shares) at Sep. 30, 2021 15,325,464     97,313 15,228,151